Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
B. Pradhan, K. Zhang, Y. Li…·L. Kauppi
The paper investigates L1 retrotransposition in HGSC, finding that despite high L1 mRNA expression, only a third of tumors show somatic insertions, with variability in retrotransposition frequency and patterns.
A. Lahtinen, K. Lavikka, Y. Li…·S. Hautaniemi
This study identifies three evolutionary states of ovarian high-grade serous carcinoma using whole-genome sequencing and links them to distinct therapeutic targets.
W. Senkowski, L. Gall-Mas, M. M. Falco…·K. Wennerberg
This paper describes a method to generate and expand high-grade serous ovarian cancer organoids with improved success rates and reports their drug response correlation with clinical outcomes.
A. N. Cvrljevic, U. Butt, K. Huhtinen…·J. Westermarck
The paper identifies ovarian cancers with low CIP2A expression as a subtype sensitive to APR-246, a ROS-inducing compound, and shows CIP2A's role in modulating NF-kB activity and drug response.